NY-ESO-1 is a ubiquitous immunotherapeutic target antigen for patients with myxoid/round cell liposarcoma

Seth M. Pollack, Achim A. Jungbluth, Benjamin L. Hoch, Erik A. Farrar, Marie Bleakley, David J. Schneider, Elizabeth T. Loggers, Eve Rodler, Janet F. Eary, Ernest U. Conrad, Robin L. Jones, Cassian Yee

Research output: Contribution to journalArticlepeer-review

78 Scopus citations

Fingerprint

Dive into the research topics of 'NY-ESO-1 is a ubiquitous immunotherapeutic target antigen for patients with myxoid/round cell liposarcoma'. Together they form a unique fingerprint.

Medicine & Life Sciences